Middle East and Africa Anatomic Pathology Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product and Service (Instruments, Consumables, and Services), Application (Disease Diagnosis, Drug Discovery and Development, and Others) and End user (Hospitals, Research Laboratories, Diagnostic Laboratories, and Others)
Market Introduction
The anatomic pathology is a significant part of the study and treatment of the diseases. Anatomic pathology is a broad field that includes decedent pathology, surgical pathology, cytopathology, neuropathology, and ophthalmic pathology. The anatomic pathology is usually performed in the medical laboratories of hospitals and diagnostics laboratories.
Get more information on this report : 
Market Overview and Dynamics
The Middle East and Africa anatomic pathology market is expected to reach US$ 1,117.01 million by 2028 from US$ 840.20 million in 2021; it is estimated to grow at a CAGR of 4.2% from 2021 to 2028. The growth of the market is attributed to some key driving factors such as increase in prevalence of cancer and other diseases, growing focus on personalized medicines are driving the growth of the Middle East and Africa anatomic pathology market. However, the market is being hampered by lack of skilled professionals and stringency of government regulations.
Personalized medicines are mainly designed by considering individuals’ genetic profiles to guide decisions made with respect to the prevention, diagnosis, and treatment of a disease. They provide an opportunity for medical device and drug manufacturers to develop agents that are targeted to patient groups that do not respond to medications as intended or that do not respond as expected to the traditional healthcare practices. There is much evidence indicating that a substantial portion of the variability in drug response depends on factors that are genetically controlled, e.g., age, nutrition, environmental exposure, and health status. Genomics plays an important role in the emergence of personalized medicines, as having the knowledge of a patient's genetic profile would help doctors in selecting an apt medication. Personalized medicines are useful for improving healthcare by enabling each patient to receive earlier diagnoses, risk assessments, and optimal treatments. The pathologists plays an important role in developing and implementing molecular and genomic tests in practice. Personalized medicines are used in the treatment of diseases such as breast cancer and cardiovascular diseases. The personalized anticancer medicines exhibit fewer and less severe side effects than other types of treatment as they are designed for more specific action. Further, with the ongoing progress in research and clinical studies, personalized medicines are likely to reach even greater potential to improve the quality of patient care. Thus, the growing focus on personalized medicines is boosting the anatomic pathology market growth. Also, the rising number of clinical trials for the anticancer drugs is likely to support for the growth of the anatomic pathology market in the coming years.
The impact of the COVID-19 pandemic on cancer patients is high in terms of anxiety, fear, and psychological distress. Moreover, the supply of diagnostics kits and assays is delayed because of the increase in quarantine time and the shutdown of all business operations. The COVID-19 pandemic has become the largest challenge to this region. For instance, due to the high uncertainty of the spread of COVID-19, the impact on Africa is expected to be severe, given the continent’s exposure to China. The COVID-19 outbreak has hampered the already weak healthcare systems in Africa. Due to the necessity of laboratory capacity and medical supplies, detecting the virus in African countries is a challenge. To overcome this challenge, the WHO helped 36 African countries with virus testing kits. Also, they are training and providing personal shielding equipment to health workers in Africa. however, it has a negative impact on the Middle East and Africa anatomic pathology market in coming years.
Key Market Segments
Based on product and service, the Middle East and Africa anatomic pathology market is segmented into instruments, consumables, and services. The services segment is likely to hold the largest share of the market in 2021, however, instruments segment is anticipated to register the highest CAGR of the market during the forecast period.
Based on application, the Middle East and Africa anatomic pathology market is segmented into disease diagnosis, drug discovery and development, and others. The disease diagnosis segment is likely to hold the largest share of the market in 2021, however, drug discovery and development segment is anticipated to register the highest CAGR of the market during the forecast period.
Based on end user, the Middle East and Africa anatomic pathology market is segmented into hospitals, research laboratories, diagnostic laboratories, and others. Others includes pharmaceutical and biotechnology companies, and contract research organization (CROs). The hospitals segment is likely to hold the largest share of the market in 2021, however, diagnostic laboratories segment is anticipated to register the highest CAGR of the market during the forecast period.
Major Sources and Companies Listed
A few of the primary and secondary sources associated with this report on the Middle East and Africa anatomic pathology market are the Centers for Disease Control and Prevention (CDC), Gulf Cooperation Council (GCC) and World Health Organization (WHO).
Reasons to buy the report
- Determine prospective investment areas based on a detailed trend analysis of Middle East and Africa anatomic pathology market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
- Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels driving the Middle East and Africa anatomic pathology market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
- Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Middle East and Africa anatomic pathology market.
MIDDLE EAST AND AFRICA ANATOMIC PATHOLOGY MARKET SEGMENTATION
By Products and Services
- Services
- Consumables
- Instruments
By Application
- Disease Diagnosis
- Drug Discovery and Development
- Others
By End User
- Hospitals
- Research Laboratories
- Diagnostic Laboratories
- Others
By Country
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East and Africa
Company Profiles
- F. HOFFMANN-LA ROCHE LTD.
- Danaher
- Hologic, Inc.
- Agilent Technologies, Inc.
- BioGenex
- Diapath S.p.A.
- Bio SB
- MERCK KGaA
- BD
- PHC Holdings Corporation
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East and Africa Anatomic Pathology Market – By Product and Services
1.3.2 Middle East and Africa Anatomic Pathology Market – By Application
1.3.3 Middle East and Africa Anatomic Pathology Market – By End User
1.3.4 Middle East and Africa Anatomic Pathology Market – By Country
2. Anatomic Pathology Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Anatomic Pathology Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Middle East and Africa (MEA) – PEST Analysis
4.3 Expert Opinions
5. Anatomic Pathology Market — Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increase in Prevalence of Cancer and Other Diseases
5.1.2 Growing Focus on Personalized Medicines
5.2 Key Market Restraints
5.2.1 Lack of Skilled Professionals
5.2.2 Stringency of Government Regulations
5.3 Key Market Opportunities
5.3.1 Rise in Number of Clinical Trials for Anticancer Drugs
5.4 Future Trends
5.4.1 Development of New Technologies and Launch of Products
5.5 Impact Analysis
6. Anatomic Pathology Market –Middle East and Africa Analysis
6.1 Middle East and Africa Anatomic Pathology Market Revenue Forecast and Analysis
7. Anatomic Pathology Market Analysis – By Product and Service
7.1 Overview
7.2 Anatomic Pathology Market, by Product and Service (2020 and 2028)
7.3 Instruments
7.3.1 Overview
7.3.2 Instruments: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Consumables
7.4.1 Overview
7.4.2 Consumables: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Services
7.5.1 Overview
7.5.2 Services: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
8. Anatomic Pathology Market Analysis – By Application
8.1 Overview
8.2 Anatomic Pathology Market, by Application (2020 and 2028)
8.3 Disease Diagnosis
8.3.1 Overview
8.3.2 Disease Diagnosis: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Drug Discovery and Development
8.4.1 Overview
8.4.2 Drug Discovery and Development: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
9. Anatomic Pathology Market Analysis – By End User
9.1 Overview
9.2 Anatomic Pathology Market, by End User (2020 and 2028)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Research Laboratories
9.4.1 Overview
9.4.2 Research Laboratories: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Diagnostic Laboratories
9.5.1 Overview
9.5.2 Diagnostic Laboratories: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
10. Anatomic Pathology Market – Middle East and Africa Analysis
10.1 Middle East and Africa: Anatomic Pathology Market
10.1.1 Overview
10.1.2 Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast to 2028 (US$ Million)
10.1.3 Middle East and Africa Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
1.1.1.1 Middle East and Africa Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.4 Middle East and Africa Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.5 Middle East and Africa: Anatomic Pathology Market, by Country, 2021 & 2028 (%)
10.1.5.1 Saudi Arabia: Anatomic Pathology Market - Revenue and Forecast to 2028 (USD Million)
10.1.5.1.1 Saudi Arabia: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
10.1.6 Saudi Arabia Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
10.1.7 Saudi Arabia Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.8 Saudi Arabia Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.8.1 UAE: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
10.1.8.1.1 UAE: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
10.1.9 UAE Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
1.1.1.2 UAE Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.10 UAE Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.10.1 South Africa: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
10.1.10.1.1 South Africa: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
10.1.11 South Africa Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
10.1.12 South Africa Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.13 South Africa Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.13.1 Rest of Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast to 2028 (USD Million)
10.1.13.1.1 Rest of Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast to 2028 (USD Million)
10.1.14 Rest of Middle East and Africa Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
1.1.1.3 Rest of Middle East and Africa Anatomic Pathology Market, by Services – Revenue and Forecast to 2028 (USD Million)
1.1.1.4 Rest of Middle East and Africa Anatomic Pathology Market, by Instruments – Revenue and Forecast to 2028 (USD Million)
10.1.15 Rest of Middle East and Africa Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.16 Rest of Middle East and Africa Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)
11. Impact of COVID-19 Pandemic on Middle East and Africa Anatomic Pathology Market
11.1 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
12. Anatomic Pathology Market– Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 F.HOFFMANN-LA ROCHE LTD.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Danaher
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Hologic, Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 BioGenex
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Diapath S.p.A.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Bio SB
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 MERCK KGaA
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 BD
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 PHC Holdings Corporation
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Middle East and Africa Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
Table 2. Middle East and Africa Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 3. Middle East and Africa Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 4. Saudi Arabia Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
Table 5. Saudi Arabia Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 6. Saudi Arabia Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 7. UAE Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
Table 8. UAE Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 9. UAE Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 10. South Africa Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
Table 11. South Africa Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 12. South Africa Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 13. Rest of Middle East and Africa Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
Table 14. Rest of Middle East and Africa Anatomic Pathology Market, by Services – Revenue and Forecast to 2028 (USD Million)
Table 15. Rest of Middle East and Africa Anatomic Pathology Market, by Instruments – Revenue and Forecast to 2028 (USD Million)
Table 16. Rest of Middle East and Africa Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 17. Rest of Middle East and Africa Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 18. Organic Developments Done by Companies
Table 19. Inorganic Developments Done by Companies
Table 20. Glossary of Terms, Anatomic Pathology Market
LIST OF FIGURES
Figure 1. Anatomic Pathology Market Segmentation
Figure 2. Anatomic Pathology Market Segmentation, By Country
Figure 3. Anatomic Pathology Market Overview
Figure 4. Services Segment Held Largest Share of Anatomic Pathology Market
Figure 5. Middle East and Africa Anatomic Pathology Market – Leading Country Markets (US$ Million)
Figure 6. Middle East and Africa (MEA) PEST Analysis
Figure 7. Middle East and Africa Anatomic Pathology Market Impact Analysis of Drivers and Restraints
Figure 8. Middle East and Africa Anatomic Pathology Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. Anatomic Pathology Market Revenue Share, by Product and Service (2020 and 2028)
Figure 10. Instruments: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Consumables: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Services: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Anatomic Pathology Market Revenue Share, by Application (2020 and 2028)
Figure 14. Disease Diagnosis: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Drug Discovery and Development: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Others: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Anatomic Pathology Market Revenue Share, by End User (2020 and 2028)
Figure 18. Hospitals: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Research Laboratories: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Diagnostic Laboratories: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Others: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Middle East and Africa: Anatomic Pathology Market, by Key Country – Revenue (2021) (USD Million)
Figure 23. Middle East and Africa Anatomic Pathology Market Revenue and Forecast to 2028 (USD Million)
Figure 24. Middle East and Africa: Anatomic Pathology Market, by Country, 2021 & 2028 (%)
Figure 25. Saudi Arabia: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
Figure 26. UAE: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
Figure 27. South Africa: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. Rest of Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast to 2028 (USD Million)
Figure 29. Impact Of COVID-19 Pandemic in Middle East and Africa Countries Market
- F. HOFFMANN-LA ROCHE LTD.
- Danaher
- Hologic, Inc.
- Agilent Technologies, Inc.
- BioGenex
- Diapath S.p.A.
- Bio SB
- MERCK KGaA
- BD
- PHC Holdings Corporation
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East and Africa anatomic pathology market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East and Africa anatomic pathology market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.